CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury.
CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury.
复制标题
DOI:
10.1097/shk.0b013e31828f9c92
复制
发表时间:
2013-05
期刊:
影响因子:
--
通讯作者:
Ward PA
中科院分区:
文献类型:
--
作者:
Bosmann M;Grailer JJ;Russkamp NF;Ruemmler R;Zetoune FS;Sarma JV;Ward PA
Acute lung injury (ALI) is a severe pulmonary disease causing high numbers of fatalities worldwide. Innate immune responses are an integral part of the pathophysiologic events during ALI. Interleukin-23 (IL-23) is a proinflammatory mediator known to direct the inflammatory responses in various settings of infection, autoimmunity and cancer. IL-23 has been associated with proliferation and effector functions in Th17 cells. Surprisingly, little is known about production of IL-23 during ALI. In this study we found expression of mRNA for IL-23p19 to be 10-fold elevated in lung homogenates of C57BL/6 mice after lipopolysaccharide (LPS)-induced ALI. Likewise, concentrations of IL-23, protein significantly increased in bronchoalveolar lavage fluids. Experiments with IL-23 deficient mice showed that endogenous IL-23 was required for production of IL-17A during LPS-ALI. CD11c-diphtheria toxin receptor transgenic mice were used to selectively deplete CD11c+ cells, the data suggesting that IL-23 production is dependent at least in part on CD11c+ cells during ALI. No alterations of IL-23 levels were observed in Rag-1 deficient mice as compared to wild type C57BL/6 mice following ALI. The mouse alveolar macrophage cell line, MH-S, as well as primary alveolar macrophages displayed abundant surface expression of CD11c. Activation of these macrophages by LPS resulted in release of IL-23 in vitro. Our findings identify CD11c+ macrophages in the lung are likely an important source of IL-23 during ALI, which may be helpful for better understanding of this disease.